pH/GSH Dual-responsive Fe-based MOF drug carrier for ferroptosis-glycolysis synergistic therapy

Abstract

Ferroptosis, a recently recognized form of non-classical programmed cell death (PCD), leads to impaired cellular structure and integrity due to the accumulation of lipid peroxidation products (LPO). However, single treatment ferroptosis often fails to achieve optimal tumor treatment outcome. Therefore, we constructed a multi-synergistic treatment strategy based on ferroptosis, that is more conducive to tumor therapy. In this study, we constructed a metal organic framework (MOF) loaded with glucose oxidase (GOx) and doxorubicin (DOX), denoted as Fe(Ⅲ)-RSSR@DOX@PEG-GOx. Fe(Ⅲ)-RSSR@DOX@PEG-GOx was synthesized through coordination between Fe3+ and disulfide-containing ligands scavenged GSH and downregulate glutathione peroxidase 4 (GPX4), thereby triggering ferroptosis. The GOx catalyzes glucose into abundant H2O2, promoting the Fenton reaction which results in excessive ROS formation within tumors. The accumulation of ROS can further enhance the process of ferroptosis, while the massive consumption of glucose constitutes a synergistic situation of “starvation treatment”. The smart biomimetic nanoplatform integrates ferroptosis, chemotherapy, and starvation therapy, providing a potential anti-tumor strategy to achieving multi-effect synergistic tumor treatment.

Article information

Article type
Paper
Submitted
03 Mar 2025
Accepted
05 Jun 2025
First published
05 Jun 2025

New J. Chem., 2025, Accepted Manuscript

pH/GSH Dual-responsive Fe-based MOF drug carrier for ferroptosis-glycolysis synergistic therapy

H. Yao, R. Ji, X. Song, B. Yang, Y. Lv and Z. Wei, New J. Chem., 2025, Accepted Manuscript , DOI: 10.1039/D5NJ00944H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements